First Tracks Biotherapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXV3d

   First Tracks Biotherapeutics raises $200M

   • Issued 6,106,870 shares at $32.75 each
   • Expected to close on Oct 19, 2026
   • Gross proceeds of $200M before fees
2. ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXV6d

   First Tracks Biotherapeutics updates investor presentation

   • Filed Form 8-K on 2026-10-13
   • Updated corporate investor presentation on 2026-10-12
   • Issued press release with positive Phase 1b data for ANB033
3. ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVSep 17

   John A Orwin, insider filing for TRAXV

   John A Orwin, reporting

4. ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVSep 4

   J. Anthony Ware, insider filing for TRAXV

   J. Anthony Ware, reporting

5. ROUTINE144First Tracks Biotherapeutics, Inc.TRAXVSep 2

   J. Anthony Ware, planned sale of TRAXV shares

   J. Anthony Ware, reporting

6. ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVAug 18

   3 insider filings

   Daniel Faga, insider filing for TRAXV

   Show all 3

   • 4Insider filing for TRAXVAug 18
   • 4Insider filing for TRAXVAug 18
   • 4Insider filing for TRAXVAug 18

   Daniel Faga, reporting

7. ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVAug 14

   Ownership stake disclosure by TCG Crossover GP II, LLC

   TCG Crossover GP II, LLC, filed by

8. ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVAug 14

   Ownership stake disclosure by Sirenia Capital Management LP

   Sirenia Capital Management LP, filed by

9. ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVAug 13

   Ownership stake disclosure by Affinity Asset Advisors, LLC

   Affinity Asset Advisors, LLC, filed by

10. ROUTINE424B3First Tracks Biotherapeutics, Inc.TRAXVAug 13

    Securities offering

11. NOTABLE10-QFirst Tracks Biotherapeutics, Inc.TRAXVAug 12

    Quarterly report

12. ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXVAug 12

    Current report

13. ROUTINE3/AFirst Tracks Biotherapeutics, Inc.TRAXVAug 7

    3 insider filings

    Paul F. Lizzul, new insider at TRAXV (amended)

    Show all 3

    • 3/ANew insider at TRAXV (amended)Aug 7
    • 3/ANew insider at TRAXV (amended)Aug 7
    • 3/ANew insider at TRAXV (amended)Aug 7

    Paul F. Lizzul, reporting

14. ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVAug 6

    Ownership stake disclosure by FMR LLC

    FMR LLC, filed by

15. ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVAug 5

    3 insider filings

    Benjamin Stone, insider filing for TRAXV

    Show all 3

    • 4Insider filing for TRAXVAug 5
    • 4Insider filing for TRAXVAug 5
    • 4Insider filing for TRAXVAug 5

    Benjamin Stone, reporting

16. ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVJul 28

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

17. ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXVJun 22

    Current report

18. ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVJun 17

    6 insider filings

    J. Anthony Ware, insider filing for TRAXV

    Show all 6

    • 4Insider filing for TRAXVJun 17
    • 4Insider filing for TRAXVJun 17
    • 4Insider filing for TRAXVJun 17
    • 4Insider filing for TRAXVJun 17
    • 4Insider filing for TRAXVJun 17
    • 4Insider filing for TRAXVJun 17

    J. Anthony Ware, reporting

19. ROUTINE4/AFirst Tracks Biotherapeutics, Inc.TRAXVJun 12

    6 insider filings

    Dennis M Fenton, insider filing for TRAXV (amended)

    Show all 6

    • 4/AInsider filing for TRAXV (amended)Jun 12
    • 4/AInsider filing for TRAXV (amended)Jun 12
    • 4/AInsider filing for TRAXV (amended)Jun 12
    • 4/AInsider filing for TRAXV (amended)Jun 12
    • 4/AInsider filing for TRAXV (amended)Jun 12
    • 4/AInsider filing for TRAXV (amended)Jun 12

    Dennis M Fenton, reporting

20. ROUTINE424B3First Tracks Biotherapeutics, Inc.TRAXVMay 15

    Securities offering

21. ROUTINE424B3First Tracks Biotherapeutics, Inc.TRAXVMay 14

    Securities offering

22. NOTABLE10-QFirst Tracks Biotherapeutics, Inc.TRAXVMay 14

    Quarterly report

23. ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXVMay 14

    Current report

24. ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVMay 14

    10 insider filings

    Rita Jain, insider filing for TRAXV

    Show all 10

    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14
    • 4Insider filing for TRAXVMay 14

    Rita Jain, reporting

25. ROUTINEEFFECTFirst Tracks Biotherapeutics, Inc.TRAXVMay 13

    Registration declared effective

Older filings on EDGAR